← FDA Drug Approvals (Drugs@FDA)

PLERIXAFOR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD VI · Approved 2025-06-16

Drug application

FDA Application #

ANDA217560

Application type

Abbreviated New Drug Application (Generic)

Brand name

PLERIXAFOR

Generic name

PLERIXAFOR

Active ingredients

PLERIXAFOR

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

HETERO LABS LTD VI

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2025-06-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown